Dataset Information


Simvastatin-induced sphingosine 1-phosphate receptor 1 expression is KLF2-dependent in human lung endothelial cells.

ABSTRACT: We have demonstrated that simvastatin and sphingosine 1-phosphate (S1P) both attenuate increased vascular permeability in preclinical models of acute respiratory distress syndrome. However, the underlying mechanisms remain unclear. As Krüppel-like factor 2 (KLF2) serves as a critical regulator for cellular stress response in endothelial cells (EC), we hypothesized that simvastatin enhances endothelial barrier function via increasing expression of the barrier-promoting S1P receptor, S1PR1, via a KLF2-dependent mechanism. S1PR1 luciferase reporter promoter activity in human lung artery EC (HPAEC) was tested after simvastatin (5??M), and S1PR1 and KLF2 protein expression detected by immunoblotting. In vivo, transcription and expression of S1PR1 and KLF2 in mice lungs were detected by microarray profiling and immunoblotting after exposure to simvastatin (10?mg/kg). Endothelial barrier function was measured by trans-endothelial electrical resistance with the S1PR1 agonist FTY720-(S)-phosphonate. Both S1PR1 and KLF2 gene expression (mRNA, protein) were significantly increased by simvastatin in vitro and in vivo. S1PR1 promoter activity was significantly increased by simvastatin (P?

PROVIDER: S-EPMC5448536 | BioStudies |

REPOSITORIES: biostudies

Similar Datasets

| S-EPMC7226983 | BioStudies
| S-EPMC3651873 | BioStudies
| S-EPMC7778601 | BioStudies
2022-07-11 | GSE207789 | GEO
| S-EPMC7054001 | BioStudies
| S-EPMC3163385 | BioStudies
| S-EPMC6773441 | BioStudies
| S-EPMC4768813 | BioStudies
2013-01-01 | S-EPMC3587808 | BioStudies
| S-EPMC2440433 | BioStudies